Cranberry plus Kürbiskern – effektive Therapie bei Harnwegsinfekten

Zusammenfassung

Die antibakterielle Wirkung der Cranberry wurde in vielen Studien belegt. Insbesondere konnte die Hemmung der Adhärenz von Bakterien (v. a. der relevanten E. coli) an die Epithelzellen der Harnwege festgestellt werden [1]–[6], durch Proanthocyanidine. Die Verhinderung der Adhärenz stellt ein wirkungsvolles Vorgehen gegen bakterielle Erkrankungen dar, auch bei chronischer Kolonisation, die bei Patienten mit wiederkehrenden Harnwegsinfekten häufig vorliegt. In der Praxis hat sich die Kombination der Cranberry mit Kürbiskernextrakten bewährt, um gleichzeitig die Blasenfunktion zu stärken.

Abstract

The antibacterial effect of the cranberry has been documented in many studies. Especially the inhibition of the adherence of bacteria (esp. the relevant E. coli) to the epithelial cells of the urinary tract by proanthocyanidine has been established [1], [2], [3], [4], [5], [6]. The prevention of the adherence is an effective procedure against bacterial diseases. This is also true in the case of chronical colonization, which is often present in patients with recurring urinary tract infections. In practice, the combination of the cranberry with pumpkin seed extracts has proven its worth, to strengthen the function of the bladder at the same time.

Schlüsselwörter

Cranberry - Kürbiskern - Harnwegsinfekt

Keywords

Cranberry - pumpkin seed - urinary tract infection

Literatur

• 01 Dugoua J J. et al . Safety and efficacy of cranberry (vaccinium macrocarpon) during pregnancy and lactation.  Can J Clin Pharmacol. 2008;  15 e80-e86
• 02 Valentova K. et al . Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: a pilot double-blind placebo-controlled trial.  J Agricn Food Chem. 2007;  55 3217-3224
• 03 Avorn J. The effect of cranberry juice on the presence of bacteria and white blood cells in the urine of elderly women. What is the role of bacterial adhesion?.  Adv Exp Med Biol. 1996;  408 185-186
• 04 Lee Y L. et al . Does cranberry juice have antibacterial activity?.  JAMA. 2000;  283 1691
• 05 Bruyere F. Use of cranberry in chronic urinary tract infections.  Med Mal Infect. 2006;  36 358-363
• 06 Schmidt D R. et al . An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates.  Microbios. 1988;  55 173-181
• 07 Johnson J R. et al . Indentification of urovirulence traits in Escherichia coli by comparison of urinary and rectal E.coli isolates from drugs with urinary tract infaction.  J Clin Microbiol. 2003;  337-345
• 08 Säemann M D. et al . Ursachen der rezividierenden Harnwegsinfektionen: neue Erkentnisse.  Dtsch Med Wochenschr. 2005;  130 2031-2034
• 09 Arthur M. et al . Molecular epidemiology of adhesion and hemolysin virulence factors among uropathogenic Escherichia coli.  Infect Immun. 1989;  57 303-313
• 10 Nowack R. Prophylaxe von bakteriellen Infektionen mit Cranberrysaft-Wirkprinzip und Evidenz.  OM & Ernährung. 2007;  118 19-25
• 11 AFSSA, Agence française de sécurité sanitaire des aliments .Saisine numéro 2003-SA-0352. 
• 12 Seeram N P. et al . Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines.  J Agric Food Chem. 2004;  52 2512-2517
• 13 McKay D L. et al . Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors.  Nutr Rev. 2007;  65 490-502
• 14 Mulabagal V. et al . Cultivars of apple fruits that are not marketed with potential for anthocyanin production.  J Agric Food Chem. 2007;  55 8165-8169
• 15 Wilson T. et al . Human glycemic response and phenolic content of unsweetened cranberry juice.  J Med Food. 2008;  11 46-54
• 16 Ofek I. et al . Anti-Escherichia adhesion activity of cranberry and blueberry juices.  Adv Exp Med Biol. 1996;  408 179-183
• 17 Ofek I. et al . Anti-Escherichia coli adhesion activity of cranberry and blueberry juices.  New Engl J Med. 1991;  324 1599
• 18 Howell A B. et al . Inhibition of the adherence of p-fimbriated Escherichia coli to uroepithelial cell surfaces by proanthocyanidin extracts from cranberries.  N Engl J Med. 1998;  339 1085
• 19 Neto C C. et al . MALDI-TOF MS characterization of proanthocyanidins from cranberry fruit (Vaccinium macrocarpon) that inhibit tumor cell growth and matrix metalloproteinase expression in vitro.  Journal of Science of Food and Agriculture. 2006;  86 (1) 18-25
• 20 Foo L Y. et al . A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli.  J Nat Prod. 2000a;  63 1225-1228
• 21 Howell A B. et al . A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity.  Phytochemistry. 2005;  66 (18) 2281-2291
• 22 Jepson R G. et al .Cranberries for treating urinary tract infections. Cochrane Database Syst Rev 2000b CD001322
• 23 Jones A H. The next step in infectious disease: taming bacteria.  Med Hypotheses. 2003;  60 171-174
• 24 Kahn H D. et al . Effect of cranberry juice on urine.  J Am Diet Assoc. 1967;  51 251-254
• 25 Kandil F E. et al . Composition of a chemopreventive proanthocyanidin-rich fraction from cranberry fruits responsible for the inhibition of 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced ornithine decarboxylase (ODC) activity.  J Agric Food Chem. 2002;  50 1063-1069
• 26 Katz L M. Reduction of bacteriuria and pyuria using cranberry juice.  JAMA. 1994;  272 589-590
• 27 Kemper K J. Cranberry therapy for children’s urinary tract infections.  Arch Pediatr Adolesc Med. 2006;  160 451-452
• 28 Kerr K G. Cranberry juice and prevention of recurrent urinary tract infection.  Lancet. 1999;  353 673
• 29 Foo L Y. et al . The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro.  Phytochemistry. 2000b;  54 173-181
• 30 Ahuja S. et al . Loss of fimbrial adhesion with the addition of Vaccinium macrocarpon to the growth medium of p-fimbriated E. coli.  J Urol. 1998;  159 559-562
• 31 Liu Y. et al . Role of cranberry juice on molecular-scale surface characteristics and adhesion behaviour of Escherichia coli.  Biotechnol Bioeng. 2006;  93 (2) 297-305
• 32 Sobota A E. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections.  J Urol. 1984;  131 1013-1016
• 33 Nowack R. Cranberry juice – a well-characterized folk-remedy against bacterial urinary tract infection.  Wien Med Wochenschr. 2007;  157 325-330
• 34 Avorn J. et al . Reduction of bacteriuria and pyuria after ingestion of cranberry juice.  JAMA. 1994;  271 751-754
• 35 Han C H. et al . Protective effects of cranberries on infection-induced oxidative renal damage in a rabbit model of vesico-ureteric reflux.  BJU Int. 2007;  100 1172-1175
• 36 Wang S Y. et al . Scavenging capacity of berry crops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen.  J Agric Food Chem. 2000;  48 5677-5684
• 37 Cimolai N. et al . The cranberry and the urinary tract.  Eur J Clin Microbiol Infect Dis. 2007;  26 767-776
• 38 Santillo V M. et al . Cranberry juice for the prevention and treatment of urinary tract infections.  Drugs Today. 2007;  43 47-54
• 39 Griffiths P. The role of cranberry juice in the treatment of urinary tract infections.  Br J Community Nurs. 2003;  8 557-561
• 40 Ohnishi R. et al . Urinary excretion of anthocyanins in humans after cranberry juice ingestion.  Biosci Biotechnol Biochem. 2006;  70 1681-1687
• 41 Bailey D T. et al . Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study.  Phytomedicine. 2007;  14 237-241
• 42 Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women.  Can J Urol. 2002;  9 1558-1562
• 43 Burger O. et al . A high molecular mass constituent of cranberry juice inhibits helicobacter pylori adhesion to human gastric mucus.  FEMS Immunol Med Microbiol. 2000;  29 295-301
• 44 Cavanagh H M. et al . Antibacterial activity of berry fruits used for culinary purposes.  J Med Food. 2003;  6 57-61
• 45 Moen D V. Observations on the effectiveness of cranberry juice in urinary infections.  Wiss Med J. 1962;  61 282-283
• 46 Burger O. et al . Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular-weight constituent of cranberry juice.  Crit Rev Food Sci Nutr. 2002;  42 279-284
• 47 Steinberg D. et al . Effect of a high-molecular-weight component of cranberry on constituents of dental biofilm.  J Antimicrob Chemother. 2004;  54 86-89
• 48 Weiss E L. et al . Inhibitory effect of a high-molecular-weight constituent of cranberry on adhesion of oral bacteria.  Crit Rev Food Sci Nutr. 2002;  42 285-292
• 49 Yamanaka A. et al . Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation.  Oral Microbiol Immunol. 2004;  19 150-154
• 50 Duarte S. et al . Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms.  FEMS Microbiol Lett. 2006;  257 50-56
• 51 McHarg T. et al . Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation.  BJU Int. 2003;  92 765-768
• 52 Kessler T. et al . Effect of blackcurrant-, cranberry- and plum juice consumption on risk factors associated with kidney stone formation.  Eur J Clin Nutr. 2002;  56 1020-1023
• 53 Chambers B K. et al . Can cranberry supplementation benefit adults with type 2 diabetes?.  Diabetes Care. 2003;  26 2695-2696
• 54 Ebringer A. et al . Rheumatoid arthritis: proposal for the use of anti-microbial therapy in early cases.  Scand J Rheumatol. 2003;  32 2-11
• 55 Reed J. Cranberry flavonoids, atherosclerosis and cardiovascular health.  Crit Rev Food Sci Nutr. 2002;  42 301-316
• 56 Youdim K A. et al . Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults (small star, filled).  J Nutr Biochem. 2002;  13 282-288
• 57 Wilson T. et al . Cranberry extract inhibits low density lipoprotein oxidation.  Life Sci. 1998;  62 L381-L386
• 58 Boivin D. et al . Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice.  Anticancer Res. 2007;  27 937-948
• 59 Neto C C. Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases.  Mol Nutr Food Res. 2007;  51 652-664
• 60 Neto C C. Cranberry and its phytochemicals: a review of in vitro anticancer studies.  J Nutr. 2007;  137 186S-193S
• 61 Seeram N P. et al . Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro.  J Agric Food Chem. 2006;  54 9329-9339
• 62 Ferguson P J. et al . A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines.  J Nutr. 2004;  134 1529-1535
• 63 Kresty L A. et al . Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells.  J Agric Food Chem. 2008;  56 676-680
• 64 Zafra-Stone S. et al . Berry anthocyanins as novel antioxidants in human health and disease prevention.  Mol Nutr Food Res. 2007;  51 675-683
• 65 Schmidlin C. et al . Cucurbita pepo. Möglicher Einfluss auf hormonelle Ungleichgewichte bei Inkontinenz.  Phytotherapie. 2003;  16-18
• 66 Kreuter H. et al .Der Ölkürbis (Cucurbita pepo). Wissenschaftliche Tagung an der Technischen Universität Graz Züchtung-Ernährung-Pharmazie 27.–28..4..2000: S14-29
• 67 Adlercreutz H. et al . Phyto-oestrogens and Western diseases.  Ann Med. 1997;  29 95-120
• 68 Kompek A. Wirkt Kürbis?.  ÖAZ. 2004;  7 1-4

Korrespondenzadresse